InvestorsHub Logo
Followers 2775
Posts 77901
Boards Moderated 1
Alias Born 05/10/2007

Re: None

Tuesday, 05/16/2017 8:49:17 AM

Tuesday, May 16, 2017 8:49:17 AM

Post# of 234
OCUL$ Expert :Ocular method to be used for most cataract surgeries,says JMP Securities JMP Securities analyst Donald Ellis says that a key opinion leader, Dr. Cynthia Matossian, expects most U.S. cataract surgeries to incorporate Ocular Therapeutix's DEXTENZA. Ellis keeps a $25 price target and an Outperform rating on the stock.

Read more at:

http://thefly.com/landingPageNews.php?id=2553211&headline=OCUL-Ocular-Therapeutix-analyst-commentary-

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OCUL News